At Vitalab Fertility Clinic, we recently encountered a patient whose case exemplifies the intricate challenges many women face today. This patient, nearly 35 years old, presents a unique combination of factors that complicate her fertility journey: delayed childbearing, a low egg reserve, and a high body mass index (BMI) of nearly 47.
The Impact of Delayed Childbearing
In today’s society, many women delay starting their families until their mid to late 30s or even early 40s. Unlike previous generations who typically completed their families by their mid-20s, modern women often find themselves grappling with the consequences of later childbearing. Women are born with a finite number of eggs, and each month, thousands are lost. By the time women reach their mid-30s, their egg reserves are significantly depleted, making it more challenging to conceive.
The Role of Obesity in Fertility
Obesity is a significant health concern that directly impacts fertility. A high BMI can complicate the process of conception and pregnancy. Our patient’s BMI of 47 presents a double-edged sword: while her egg reserve is low, requiring prompt action, her high BMI necessitates significant weight loss for a safer pregnancy and more effective IVF treatment.
The Challenges of IVF with a High BMI
For IVF to be successful, we need to stimulate the ovaries to produce a number of eggs. Typically, we aim for 8 to 15 eggs to increase the chances of achieving a pregnancy. However, with a high BMI, the process becomes more challenging. The medication used to stimulate the ovaries must travel through a larger body mass, requiring higher doses and potentially reducing effectiveness.
Moreover, a high BMI poses additional risks during pregnancy, including higher miscarriage rates, increased chances of developing blood pressure issues, and gestational diabetes. These risks make it unsafe to proceed with a fresh embryo transfer in patients with a high BMI.
A Strategic Approach: Freezing Embryos
Given these complexities, our approach with this patient involves a strategic plan: stimulating her ovaries to produce eggs, creating embryos, and then freezing these embryos. This approach allows us to separate the stimulation phase from the transfer phase. By freezing the embryos, we provide our patient with the time needed to lose a substantial amount of weight—between 20 to 30 kg—to reduce her BMI to a safer level for pregnancy.
Frozen embryos do not have a shelf life, meaning they can be stored until the patient is in optimal health for a transfer. This approach not only increases the chances of a successful pregnancy but also ensures the safety of both the patient and the potential pregnancy.
Conclusion
Our patient’s case at Vitalab Fertility Clinic highlights the intricate balance required in fertility treatments, especially when dealing with delayed childbearing and obesity. By leveraging advanced techniques such as embryo freezing, we can navigate these challenges, providing our patients with the best possible chance of achieving a healthy pregnancy. This strategic approach underscores the importance of personalized treatment plans in addressing the unique needs of each patient.
Watch Monica’s story here